본문으로 건너뛰기
← 뒤로

Retraction notice to "Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies" [Biomedicine & Pharmacotherapy 160 (2023) 114392].

0/5 보강
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 📖 저널 OA 30.5% 2022: 0/4 OA 2023: 0/2 OA 2024: 3/16 OA 2025: 3/67 OA 2026: 51/96 OA 2022~2026 2026 p. 119216 OA
Retraction 확인
출처

Hashemi M, Zandieh MA, Talebi Y, Rahmanian P, Shafiee SS, Nejad MM

이 논문을 인용하기

↓ .bib ↓ .ris
APA Hashemi M, Zandieh MA, et al. (2026). Retraction notice to "Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies" [Biomedicine & Pharmacotherapy 160 (2023) 114392].. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 119216. https://doi.org/10.1016/j.biopha.2026.119216
MLA Hashemi M, et al.. "Retraction notice to "Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies" [Biomedicine & Pharmacotherapy 160 (2023) 114392].." Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026, pp. 119216.
PMID 41862345 ↗

같은 제1저자의 인용 많은 논문 (2)

🔓 OA PDF 열기